Amanda K Gilmore1, Constance Guille2, Nathaniel L Baker3, Kathleen T Brady2, Christine K Hahn2, Callah M Davis2, Jenna L McCauley2, Sudie E Back2. 1. College of Nursing, Medical University of South Carolina, United States; Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, United States. Electronic address: gilmoram@musc.edu. 2. Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, United States. 3. Department of Public Health Sciences, Medical University of South Carolina, United States.
Abstract
BACKGROUND: Opioid dependence is a significant public health problem in the United States and the number of opioid overdose deaths among women has increased dramatically in comparison to men in the last few years. In this context, understanding the biological mechanisms underlying gender differences in vulnerability to opioid dependence is essential. METHODS: The current pilot study examined gender differences in subjective stress, heart rate (HR), and cortisol/dephydroepiandrosterone (DHEA) response to a laboratory stressor (Trier Social Stress Test; TSST) or a no-stress condition, and drug cue paradigm among men (n = 21) and women (n = 18) with opioid dependence. RESULTS: Significant group (TSST vs. no stress) differences emerged in self-reported stress [F(1,35) = 23.8, p < .001], HR [F(1,31) = 12.3; p = .001] and cortisol (F1,34 = 5.0; p = .032) response, such that the TSST group was more reactive than the no-stress group. Women reported greater subjective stress [F(1,35) = 6.5, p <= .015] in response to the TSST compared to men. However, men evidenced marginally greater cortisol and DHEA responses to the TSST compared to women [F(1,34) = 2.7; p = .113 and F(1,31) = 3.4; p = .073, respectively]. CONCLUSIONS: Although women with opioid dependence reported greater subjective stress when exposed to a laboratory stress paradigm as compared to men, the neuroendocrine response was more robust in men. This pattern was similar to gender findings in men and women with cocaine and tobacco use disorders. The blunted cortisol combined with an increased subjective response among women may be a sign of HPA axis dysregulation which could increase vulnerability to relapse in women.
BACKGROUND: Opioid dependence is a significant public health problem in the United States and the number of opioid overdose deaths among women has increased dramatically in comparison to men in the last few years. In this context, understanding the biological mechanisms underlying gender differences in vulnerability to opioid dependence is essential. METHODS: The current pilot study examined gender differences in subjective stress, heart rate (HR), and cortisol/dephydroepiandrosterone (DHEA) response to a laboratory stressor (Trier Social Stress Test; TSST) or a no-stress condition, and drug cue paradigm among men (n = 21) and women (n = 18) with opioid dependence. RESULTS: Significant group (TSST vs. no stress) differences emerged in self-reported stress [F(1,35) = 23.8, p < .001], HR [F(1,31) = 12.3; p = .001] and cortisol (F1,34 = 5.0; p = .032) response, such that the TSST group was more reactive than the no-stress group. Women reported greater subjective stress [F(1,35) = 6.5, p <= .015] in response to the TSST compared to men. However, men evidenced marginally greater cortisol and DHEA responses to the TSST compared to women [F(1,34) = 2.7; p = .113 and F(1,31) = 3.4; p = .073, respectively]. CONCLUSIONS: Although women with opioid dependence reported greater subjective stress when exposed to a laboratory stress paradigm as compared to men, the neuroendocrine response was more robust in men. This pattern was similar to gender findings in men and women with cocaine and tobacco use disorders. The blunted cortisol combined with an increased subjective response among women may be a sign of HPA axis dysregulation which could increase vulnerability to relapse in women.
Authors: Aimee L McRae-Clark; Angie M Cason; Amy S Kohtz; Megan Moran Santa-Maria; Gary Aston-Jones; Kathleen T Brady Journal: J Neurosci Res Date: 2017-01-02 Impact factor: 4.164
Authors: Sudie E Back; Rebecca L Payne; Amy Herrin Wahlquist; Rickey E Carter; Zachary Stroud; Louise Haynes; Maureen Hillhouse; Kathleen T Brady; Walter Ling Journal: Am J Drug Alcohol Abuse Date: 2011-09 Impact factor: 3.829
Authors: Ann M Rasmusson; Jitka Vasek; Deborah S Lipschitz; Dolores Vojvoda; Mary Ellen Mustone; Quihu Shi; Gretchen Gudmundsen; Charles A Morgan; Jessica Wolfe; Dennis S Charney Journal: Neuropsychopharmacology Date: 2004-08 Impact factor: 7.853
Authors: Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones Journal: Ann Intern Med Date: 2017-08-01 Impact factor: 25.391
Authors: Caitlyn O Hood; Rachel L Tomko; Nathaniel L Baker; Breanna M Tuck; Julianne C Flanagan; Matthew J Carpenter; Kevin M Gray; Michael E Saladin; Erin A McClure Journal: Psychoneuroendocrinology Date: 2020-06-10 Impact factor: 4.905
Authors: Nathaniel L Baker; Brian Neelon; Viswanathan Ramakrishnan; Kathleen T Brady; Kevin M Gray; Michael E Saladin; Sudie E Back; Julianne C Flanagan; Constance Guille; Aimee L McRae-Clark Journal: Psychopharmacology (Berl) Date: 2022-05-20 Impact factor: 4.415
Authors: Amanda K Gilmore; Christine K Hahn; Anna E Jaffe; Kate Walsh; Angela D Moreland; Erin F Ward-Ciesielski Journal: Addict Behav Date: 2018-05-31 Impact factor: 3.913
Authors: Erin A McClure; Nathaniel L Baker; Kevin M Gray; Caitlyn O Hood; Rachel L Tomko; Matthew J Carpenter; Viswanathan R Ramakrishnan; Cole J Buchanan; Michael E Saladin Journal: Psychopharmacology (Berl) Date: 2019-12-03 Impact factor: 4.530
Authors: Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Dejun Jackson; Matthew Foster; Tamara Vujanovic; J Gaston Box; Jason J Paris Journal: Horm Behav Date: 2019-12-13 Impact factor: 3.587
Authors: Tanya C Saraiya; Amber M Jarnecke; Jennifer Jones; Delisa G Brown; Kathleen T Brady; Sudie E Back Journal: Drug Alcohol Depend Date: 2021-05-21 Impact factor: 4.852